Moral Judgements and Choices of Caregivers in the Time of COVID-19 Pandemic
NCT ID: NCT04542122
Last Updated: 2020-09-09
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
NA
500 participants
INTERVENTIONAL
2020-09-03
2021-08-02
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
How COVID-19 Virus Outbreak Affects Antimicrobial Resistance in a Low-middle-income Country's ICU?
NCT04348227
Palliative Care in Patients With COVID-19: Analysis of Costs of Hospitalization in Wards and Intensive Care Units
NCT05897229
Prevent and Control COVID-19 Infection in Nursing Homes on the Risk of Death of Residents
NCT04740658
Study of the Consequences of Infection on Compliance of Modalities of Decisions of Limitations and Stops of Treatments (COVID-19-LAT)
NCT04452487
Prevention of Nosocomial Bacteremia Among Zambian Neonates
NCT02386592
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
CROSSOVER
OTHER
TRIPLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Choices then judgements
No interventions assigned to this group
Judgements then choices
Switch in the order of clinical cases in the survey
Choices and judgements
In the intervention arm, the participant is asked to answer clinical cases in a reverse order from the control group (control has to make moral choices then judge somebody else's choices ; intervention has to judge moral choices first, then make his own)
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Choices and judgements
In the intervention arm, the participant is asked to answer clinical cases in a reverse order from the control group (control has to make moral choices then judge somebody else's choices ; intervention has to judge moral choices first, then make his own)
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Agreement
Exclusion Criteria
18 Years
99 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University of Geneva, Switzerland
OTHER
University Hospital, Caen
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Clement GAKUBA, MD PhD
Role: PRINCIPAL_INVESTIGATOR
University Hospital, Caen
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
References
Explore related publications, articles, or registry entries linked to this study.
Kahane G, Everett JAC, Earp BD, Caviola L, Faber NS, Crockett MJ, Savulescu J. Beyond sacrificial harm: A two-dimensional model of utilitarian psychology. Psychol Rev. 2018 Mar;125(2):131-164. doi: 10.1037/rev0000093. Epub 2017 Dec 21.
Garbutt G, Davies P. Should the practice of medicine be a deontological or utilitarian enterprise? J Med Ethics. 2011 May;37(5):267-70. doi: 10.1136/jme.2010.036111. Epub 2011 Jan 29.
Conway P, Goldstein-Greenwood J, Polacek D, Greene JD. Sacrificial utilitarian judgments do reflect concern for the greater good: Clarification via process dissociation and the judgments of philosophers. Cognition. 2018 Oct;179:241-265. doi: 10.1016/j.cognition.2018.04.018. Epub 2018 Jul 2.
Einav S, Benoit DD. Focus on ethics of admission and discharge policies and conflicts of interest. Intensive Care Med. 2019 Aug;45(8):1130-1132. doi: 10.1007/s00134-019-05673-3. Epub 2019 Jul 2. No abstract available.
Emanuel EJ, Persad G, Upshur R, Thome B, Parker M, Glickman A, Zhang C, Boyle C, Smith M, Phillips JP. Fair Allocation of Scarce Medical Resources in the Time of Covid-19. N Engl J Med. 2020 May 21;382(21):2049-2055. doi: 10.1056/NEJMsb2005114. Epub 2020 Mar 23. No abstract available.
Truog RD, Mitchell C, Daley GQ. The Toughest Triage - Allocating Ventilators in a Pandemic. N Engl J Med. 2020 May 21;382(21):1973-1975. doi: 10.1056/NEJMp2005689. Epub 2020 Mar 23. No abstract available.
Leclerc T, Donat N, Donat A, Pasquier P, Libert N, Schaeffer E, D'Aranda E, Cotte J, Fontaine B, Perrigault PF, Michel F, Muller L, Meaudre E, Veber B. Prioritisation of ICU treatments for critically ill patients in a COVID-19 pandemic with scarce resources. Anaesth Crit Care Pain Med. 2020 Jun;39(3):333-339. doi: 10.1016/j.accpm.2020.05.008. Epub 2020 May 17.
Rosenbaum L. Facing Covid-19 in Italy - Ethics, Logistics, and Therapeutics on the Epidemic's Front Line. N Engl J Med. 2020 May 14;382(20):1873-1875. doi: 10.1056/NEJMp2005492. Epub 2020 Mar 18. No abstract available.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
1474
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.